Embolic Protection Devices Market USD 466.7 Million in 2023

The global Embolic Protection Devices market was valued at USD 466.7 Million in 2023 and is expected to reach USD 871.4 Million by the year 2032, at a CAGR of 8.3%. Embolic Protection Devices are instruments that have their application in pre and post-cardiac surgery. Embolism is the blockage of vessels caused due to the cuts or damages caused during or post-surgery. The damages caused to the blood vessels results in the formation of blood clots and the release of debris. Removal of debris and plaques is essential because of the complication of facing edema or blockages in the specific area, which would get life-threatening. Imaging systems are attached with Embolism Protection Devices to check the severity of the obstruction hence formed.

The primary driver of the Embolic Protection Devices industry includes the increased prevalence of cardiovascular disorders and neurovascular diseases due to unhealthy diet, use of tobacco, and lack of exercise. For instance, according to the World Health Organization in 2016, global deaths due to cardiovascular diseases account for 31% out of the various other factors. Furthermore, the key drivers which are responsible for the market growth are hike in the geriatric population, technological advancements in different fields of healthcare, government initiatives for the awareness regarding pre-diagnostics of the trending chronic diseases in the forecast period. Moreover, according to the World Health Organization, the proportion of the world’s population over 60 years will nearly double from 12% to 22% between 2015 and 2050. These are some major key drivers that are expected to propel the market growth of Embolic Protection Devices during the forecast period.

Request a Sample@ https://www.qyresearchmedical.com/sample/119233

The recent advancements in visual amplification make it convenient for the healthcare provider to interpret the clinical outcome. Therefore, increased efficacy and accuracy of medical devices has been significantly improved. The compactness of the newer distal occlusive devices is helping to minimize the invasion inside the blood vessels. These innovations would help the embolic protection devices to gain traction in the forecast period.

The significant challenges include the high cost of surgeries, which was expensive and unaffordable for low-income and emerging economies. In addition to the cost-effectiveness, the increasing product failures and recalls due to the stringent guidelines of the government for the implication of surgeries are expected to hamper the growth of the embolic protection devices industry in the near future.

Key Coverage of the Report

  • Region and country-wise assessment from the period 2023-2032. For the study, 2022-2023 has been utilized as historical data, 2020 as the base year, and 2023-2032, has been derived as forecasts
  • Regional Competitors clinical pipeline analysis
  • Demand and Supply GAP Analysis
  • Market share analysis of the key industry players
  • Strategic recommendations for the new entrants
  • Market forecasts for a minimum of 6 years of all the mentioned segments, and the regional markets
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments

Salient Trends of the Embolic Protection Devices Market

  • According to the World Health Organization, in 2016, the total number of deaths due to Cardio-vascular diseases account for 31% of the total deaths worldwide, which is an alarming number. The rising awareness about importance of pre-diagnostics and quick therapy for the same would help the market to grow in the coming years.
  • According to the World Health Organization, it has been estimated that between 2015 and 2050, the proportion of the world\’s population over 60 years of age will nearly double from 12% to 22%. And hence the ratio at which the market would grow is expected to be much higher during forecast years.
  • A recent innovation brought up the requirement of the adoption of the material Nitinol. It is found to be more efficient during surgery because the property it possesses. It is less reactive and invasive to the sensitive walls of the vessels. This factor in protecting the severe damages to the blood vessels, ensuring the least invasion, would propel the demand for the product owing to the growth in the market.
  • Among the top market players, Emboline is one of the companies opting for technological advancements. The innovation brought up is Emboliner having the capacity to extract debris of size >150µm, has recently passed the clinical study tests by SAFEPASS-2, and is ready for trials in U.S. clinical study. These upgradations would fuel the growth of embolic protection devices.
  • Trans-catheter Aortic Valve Replacement centers in 2016, are observed to be 35,000 patients. This traction in need to undergo such surgeries is expected to increase the demand for Embolic Protection Devices in the near future.

Companies considered and profiled in this market study

The global Embolic Protection Devices industry study suggests key players which include Medtronic (Ireland), Abbott (US), Boston Scientific (US), Cordis (A Cardinal Health Company) (US), Allium Medical Solutions (Israel), Contego Medical (US), W.L. Gore & Associates (US), Silk Road Medical (US), Claret Medical (US), and Andioslide.


  • North America is expected to have the largest market share of 34.1% in the year 2020. Increased R&D investment, technologically advanced infrastructure in the region and increased healthcare spending are the factors which would further propel the growth of the market.
  • Neurovascular Diseases segment held a market share of 37.3% in the year 2020. The segment is further expected to grow at the rate of 8.2%, owing it to the rising demand for effective early diagnostic methods.
  • About 38.9%of the global Embolic Protection market is occupied by Distal Filter Devices segment because of the increasing need of the devices which helps eradicating the cause of the embolism.
  • Europe held a market share of 26.4% in the year 2020 with a compounded annual growth rate of 8.0% during the forecast period. The minimal invasive technique being recent demand would in turn let the Embolic Protection Devices market to grow.
  • Increasing demand for early disease diagnosis and initiatives taken by the governments in the region to ensure improvement in the quality of life will fuel the market growth in APAC.
  • Cardiovascular diseases by application segment held a share of 27.8% in the year 2020. The segment is expected to grow at the largest rate of 8.0%. This is attributed to the increase in the prevalence of Cardio-Vascular diseases according to the World Health Organisation.

Segments covered in the report

This report forecasts revenue growth at a global, regional & country level, and provides an analysis of the market trends in each of the sub-segments from 2023 to 2032. For the purpose of this study, has segmented the Embolic Protection Devices market on the basis of device, material, indication, end-use and region:

Device Outlook (Revenue in Million USD; 2023–2032)

  • Distal Filter Devices
  • Occlusion Devices
    • Distal Occlusive Devices
    • Proximal Occlusive Devices

Material Outlook (Revenue in Million USD; 2023–2032)

  • Polyurethane
  • Nitinol

Indication Outlook (Revenue in Million USD; 2023–2032)

  • Neurovascular Diseases
  • Cardio-vascular Diseases
  • Coronary Artery Disease
  • Peripheral Vascular Diseases
  • Saphenous Vein Graft Disease
  • Others

End-Use Outlook (Revenue in Million USD; 2023–2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Specialty Centers
  • Others

Regional Outlook (Revenue in Million USD; 2023–2032)

  • North America
    • U.S
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Rest of the Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of Asia-Pacific
  • Middle East & Africa
  • Latin America
    • Brazil

Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119233/1500

You can place an order or ask any questions, please feel free to contact [email protected] | +1 9197 992 333

Blog: https://www.novaoneadvisor.com/

Blog: https://www.visionresearchreports.com/

About Us

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.

For Latest Update Follow Us:

URL – http://www.qyresearchmedical.com/




Leave a Comment

Your email address will not be published. Required fields are marked *